Ajay Kirtane 2011-08-04
Current role of lower limb revascularization surgery
Roberto Sánchez 2011-08-03
Interruption of antiplatelet therapy for non-cardiac surgery
Ajay Kirtane 2011-08-03
Current role of lower limb revascularization surgery
Roberto Sánchez. 2011-08-03
Non-cardiac surgery and coronary DES
Ajay Kirtan 2011-08-04
PRAGUE 14: Anti-thrombotic therapy before non-cardiac surgery may be associated with a higher incidence of bleeding.
The majority of coronary patients are under anti-thrombotic therapy and its interruption may increase cardiovascular risk, while on the other hand, continuation during a surgical procedure may increase the risk of bleeding. This study, which included 1211 patients who underwent non-cardiac surgery, compared the interruption of anti-thrombotic therapy at least 7 days prior vs continuing...
In a decade, minimally invasive procedures will replace open-heart surgery entirely
Minimally invasive interventions allow us to respond to any complications related to the heart, so it is expected to decrease open-heart surgery dramatically; in a decade, minimally invasive procedures definitely replace conventional surgery. This was highlighted on Wednesday during the XXV Meeting of the Cardiac Catheterization and Interventional Cardiology of the Spanish Society of Cardiology...
DES and programmed surgery: reality or myth
Original title: Drug-Eluting Stents versus Bare Metal Stents Prior to Noncardiac Surgery. Reference: Sripal Bangalore, et al. Catheterization and Cardiovascular Intervention 2015;85:533-41 Drug eluting stents (DES) have proved beneficial compared to bare metal stents (BMS), but the need to program a surgical procedure after a percutaneous coronary intervention (PCI) has limited its use. This study analyzed patients receiving...
Is the 2nd generation DES an alternative to surgery in multivessel coronary disease?
The benefits of 2nd generation drug-eluting stents (DES) are being compared with Coronary artery bypass graft surgery (CABG), looking to achieve a safe, effective, less invasive and as complete as possible revascularization. As background of SYNTAX, the stent thrombosis (ST) with Taxus, reached 25% of the events in the group of intervention (PCI), so that...
Frequency, indication and evolution of emergency cardiac surgery during TAVI
Original Title: Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insight the Edwards SAPIENS Aortic Bioprosthesis Outcome (SOURCE) registry. Reference: Holger Eggerbrecht, et al. EuroIntervention 2014;10:975-81 SOURCE register data from patients receiving transcatheter aortic valve implantation with the Edwards Sapiens valve, were analyzed; out of 2307 patients, 27 (1.2%) required emergency cardiac surgery (ECS). Valve stenosis was...